UniProtKB/Swiss-Prot Q14542: Variant p.Asn68Lys

Equilibrative nucleoside transporter 2
Gene: SLC29A2
Feedback?

Variant information Variant position:

68 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Asparagine (N) to Lysine (K) at position 68 (N68K, p.Asn68Lys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and polar (N) to large size and basic (K) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

No change in nucleoside and nucleobase transport. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs8187644 [ dbSNP | Ensembl ]

Sequence information Variant position:

68 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

456 The length of the canonical sequence.
Location on the sequence:

NSTARILSTNHTGPEDAFNF N NWVTLLSQLPLLLFTLLNSF The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         NSTARILSTNHTGPEDAFNFNNWVTLLSQLPLLLFTLLNSF

Mouse                         NSSAETMGTNHTSPTDTFNFNNWVTLLSQLPLLLFTLLNSF

Rat                           NSSAETPSTNHTSPTDTFNFNNWVTLLSQLPLLLFTLLNSF

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 456	Equilibrative nucleoside transporter 2
Glycosylation	48 – 48	N-linked (GlcNAc...) asparagine
Glycosylation	57 – 57	N-linked (GlcNAc...) asparagine
Mutagenesis	48 – 48	N -> D. No difference in uridine or cytidine uptake. No differences in Km values and lower Vmax values for either uridine or cytidine uptake; when associated with D-57.
Mutagenesis	57 – 57	N -> D. No difference in uridine or cytidine uptake. No differences in Km values and lower Vmax values for either uridine or cytidine uptake; when associated with D-48.

Literature citations
Functional characterization and haplotype analysis of polymorphisms in the human equilibrative nucleoside transporter, ENT2.
Owen R.P.; Lagpacan L.L.; Taylor T.R.; De La Cruz M.; Huang C.C.; Kawamoto M.; Johns S.J.; Stryke D.; Ferrin T.E.; Giacomini K.M.;
Drug Metab. Dispos. 34:12-15(2006)
Cited for: FUNCTION; TRANSPORTER ACTIVITY; VARIANTS TYR-5; LYS-68; LEU-94 AND 184-SER--VAL-186 DELINS MET; CHARACTERIZATION OF VARIANTS TYR-5; LYS-68; LEU-94 AND 184-SER--VAL-186 DELINS MET;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.